CD38 and plasma cell myeloma: We found that primary multiple myeloma cells sensitive to SAR442257 had a CD38 MFI 6-fold brighter than the surrounding non-MM cells in culture, with the exception of two samples, HTB-1410 and HTB-1802 (Fig. 5A).